May. 07 Boston Scientific to Update Pacemakers in Recall, FDA Says DJ
May. 07 US FDA issues recall of Boston Scientific heart devices RE
May. 06 Penumbra, Inc. Reports First Quarter 2026 Financial Results PR
May. 04 Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results PR
May. 03 BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 NE
May. 02 BSX 72 HOUR DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 NE
May. 01 BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 PR
Apr. 30 BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented U.S. Electrophysiology Market Growth and Downplayed Competitive Pressures: SueWallSt PR
Apr. 29 BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 NE
Apr. 29 Boston Scientific Shares Fall After Daiwa Securities Downgrade MT
Apr. 29 HEALTH ROUNDS-Procedure using Boston Scientific device tops medication for heart rhythm problem RE
Apr. 29 BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Hid Weakening U.S. Electrophysiology Sales Trends: Levi & Korsinsky PR
Apr. 29 Daiwa Securities Downgrades Boston Scientific to Neutral From Outperform, Adjusts PT to $60 From $83 MT
Apr. 28 BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 NE
Apr. 28 Lost Money on Boston Scientific Corporation (BSX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR
Apr. 27 UBS Adjusts Boston Scientific Price Target to $95 From $105, Maintains Buy Rating MT
Apr. 27 Argus Research Adjusts Boston Scientific Price Target to $95 From $115, Maintains Buy Rating MT
Apr. 26 Data at Heart Rhythm 2026 highlight key Boston Scientific therapies PR
Apr. 26 Boston Scientific Corporation Provides Data At Heart Rhythm 2026 Highlight Key Boston Scientific Therapies CI
Apr. 25 BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 NE
Apr. 23 Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says MT
Apr. 23 BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 NE
Apr. 23 Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating MT
Apr. 23 Deutsche Bank Cuts Price Target on Boston Scientific to $75 From $90, Keeps Buy Rating MT
Apr. 23 Truist Lowers Price Target on Boston Scientific to $85 From $90, Keeps Buy Rating MT
No results for this search
  1. Stock Market
  2. Equities
  3. BSX Stock
  4. News Boston Scientific Corporation